{
    "code": "02025317",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025317",
    "time": "2020-11-27 12:59:35",
    "許可證字號": "衛署藥輸字第025317號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/01\/11",
    "發證日期": "100\/01\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202531707",
    "中文品名": "泰息安膠囊150毫克",
    "英文品名": "Tasigna Capsules 150mg",
    "適應症": "新確診之慢性期費城染色體陽性的慢性骨髓性白血病成年及兒童病人。具抗藥性或耐受性不良之慢性期費城染色體陽性的慢性骨髓細胞白血病兒童病人。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NILOTINIB HYDROCHLORIDE MONOHYDRATE",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE, CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASLE, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "025317_Tasigna Capsules 150mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tasigna 150, 200mg_TWI-171219_C-108-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=018&Type=9"
        },
        {
            "title": "Tasigna 150mg_FB_Outer box-109-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=009&Type=8"
        },
        {
            "title": "Tasigna 150mg_FB_Inner box-109-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=008&Type=8"
        },
        {
            "title": "Tasigna capsules 150mg_Package_20160111-106-08-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=007&Type=8"
        },
        {
            "title": "020253170002-105-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025317&Seq=006&Type=8"
        }
    ]
}